发现 帖子

在我们的“发现”页面上探索迷人的内容和多样化的观点。发现新想法并参与有意义的对话

Posts

用户

博客

资金
ethantaylor profile picture
ethantaylor 创建了一篇新文章
5 日

What Tolebrutinib’s UAE Approval Means for Neurology Players Entering MENA | #duphat

What Tolebrutinib’s UAE Approval Means for Neurology Players Entering MENA

What Tolebrutinib’s UAE Approval Means for Neurology Players Entering MENA

What Tolebrutinib’s UAE Approval Means for Neurology Players Entering MENA
ethantaylor profile picture
ethantaylor 创建了一篇新文章
5 日

The Evolution of Healthcare in the Middle East: From Traditional Medicine to Digital Innovation | #duphat

The Evolution of Healthcare in the Middle East: From Traditional Medicine to Digital Innovation

The Evolution of Healthcare in the Middle East: From Traditional Medicine to Digital Innovation

The Evolution of Healthcare in the Middle East: From Traditional Medicine to Digital Innovation
ethantaylor profile picture
ethantaylor 创建了一篇新文章
5 日

Why the UAE is emerging as the New Pharma and Medical Hub of the Middle East | #duphat

Why the UAE is emerging as the New Pharma and Medical Hub of the Middle East

Why the UAE is emerging as the New Pharma and Medical Hub of the Middle East

Why the UAE is emerging as the New Pharma and Medical Hub of the Middle East
ethantaylor profile picture
ethantaylor 创建了一篇新文章
6 日

Gastroparesis Pipeline Shows Strong Momentum | #gastroparesis Pipeline Shows Strong Momentum

Gastroparesis Pipeline Shows Strong Momentum

Gastroparesis Pipeline Shows Strong Momentum

Gastroparesis Pipeline Shows Strong Momentum
ethantaylor profile picture
ethantaylor 创建了一篇新文章
6 日

Top Reasons to Attend a Pharma Conference in Dubai in 2026 | #https://hanzuzhisheng.com/create-blog/

Top Reasons to Attend a Pharma Conference in Dubai in 2026

Top Reasons to Attend a Pharma Conference in Dubai in 2026

Top Reasons to Attend a Pharma Conference in Dubai in 2026
k kumar profile picture
k kumar 创建了一篇新文章
7 日

What Awaits You at the Middle East’s Leading Pharma Event | #healthcare

What Awaits You at the Middle East’s Leading Pharma Event

What Awaits You at the Middle East’s Leading Pharma Event

If you are planning to attend the biggest pharmaceutical conference and exhibition in the Middle East, here is everything you need to know about what awaits you
k kumar profile picture
k kumar 创建了一篇新文章
1 周

International Pharma Events: Top 10 Global Conferences | #healthcare

International Pharma Events: Top 10 Global Conferences

International Pharma Events: Top 10 Global Conferences

The pharmaceutical industry moves fast. Scientific breakthroughs, regulatory changes, manufacturing innovation, and digital transformation are constantly reshaping the global landscape
k kumar profile picture
k kumar 创建了一篇新文章
1 周

The Surge in Portable Pulse Oximeter Usage Globally | #healthcare

The Surge in Portable Pulse Oximeter Usage Globally

Healthcare institutions globally have integrated these devices into standard care protocols, recognizing their fundamental contribution to patient safety and clinical decision-making
k kumar profile picture
k kumar 创建了一篇新文章
1 周

DelveInsight预测，线粒体肌病市场有望在2025年至2034年间以26.5%的复合年增长率实现显著增长，这主要得益于突破性药物获批、在研候选药物不断推进以及疾病认知度的提高 | | #healthcare

DelveInsight预测，线粒体肌病市场有望在2025年至2034年间以26.5%的复合年增长率实现显著增长，这主要得益于突破性药物获批、在研候选药物不断推进以及疾病认知度的提高 |

DelveInsight预测，线粒体肌病市场有望在2025年至2034年间以26.5%的复合年增长率实现显著增长，这主要得益于突破性药物获批、在研候选药物不断推进以及疾病认知度的提高 |

线粒体肌病治疗市场预计将保持强劲且持续的增长，这主要得益于FORZINITY和KYGEVVI的里程碑式获批、诊断能力的提升以及公众对该疾病认知的提高。此外，诸如Sonlicromanol（Khondrion公司；氧化还原调节剂）、KL1333（Pharming公
k kumar profile picture
k kumar 创建了一篇新文章
1 周

DelveInsight报告称，2024-2034年预测期内，慢性阻塞性肺病（COPD）市场有望显著扩张 | 主要参与者包括基因泰克、葛兰素史克、维罗纳制药、再生元、赛诺菲、MedImmune、EpiEndo制药和Tetherex制药。 | #healthcare

DelveInsight报告称，2024-2034年预测期内，慢性阻塞性肺病（COPD）市场有望显著扩张 | 主要参与者包括基因泰克、葛兰素史克、维罗纳制药、再生元、赛诺菲、MedImmune、EpiEndo制药和Tetherex制药。

DelveInsight报告称，2024-2034年预测期内，慢性阻塞性肺病（COPD）市场有望显著扩张 | 主要参与者包括基因泰克、葛兰素史克、维罗纳制药、再生元、赛诺菲、MedImmune、EpiEndo制药和Tetherex制药。

引领慢性阻塞性肺病 (COPD) 治疗格局的领先公司包括 Genentech, Inc.、GlaxoSmithKline、Verona Pharma plc、Regeneron Pharmaceuticals、Sanofi、MedImmune LLC、EpiEndo Pharmaceuticals、Tetherex Pharmaceuticals、AstraZeneca、Chiesi Farmaceutici S.p.A.、Synairgen Resear
Showing 2 out of 395